Chat with GenHealth to automate any coding or chart task.
Name of the Procedure:
Injection, butorphanol tartrate, 1 mg
Common names: Butorphanol injection, Stadol injection Technical terms: Butorphanol tartrate injection
Summary
This procedure involves the administration of butorphanol tartrate, a medication used for pain relief. It is delivered via an injection, typically into muscle tissue or intravenously.
Purpose
Medical conditions addressed: Severe pain management, often related to surgery, injury, or migraines. Goals: Rapid and effective relief from acute or chronic pain.
Indications
Symptoms: Intense, acute pain; moderate to severe chronic pain conditions. Patient criteria: Adults experiencing severe pain unrelieved by other analgesics, patients needing short-term pain control, or those intolerant or allergic to other pain medications.
Preparation
Pre-procedure instructions: Generally, no extensive preparation is needed. Patients should inform their doctor of all medications they are taking and any history of allergies or reactions to pain medications. Diagnostic tests: No specific tests required; medical history and a physical examination generally suffice.
Procedure Description
- The healthcare professional will clean the injection site with antiseptic.
- Using a sterile needle and syringe, they will draw up the correct dosage (1 mg) of butorphanol tartrate.
- The medication is then injected into a muscle (intramuscular) or directly into a vein (intravenous).
- Patients are monitored for any immediate reactions.
Tools: Syringe, sterile needle, antiseptic wipes. Anesthesia or Sedation: Typically, no anesthesia or sedation, but local anesthesia may be applied in some cases for patient comfort.
Duration
The actual injection takes just a few minutes, although monitoring for adverse reactions may take an additional 15-30 minutes.
Setting
Location: The procedure is usually done in a hospital, outpatient clinic, or doctor's office.
Personnel
Healthcare professionals involved: Doctor, nurse, or trained medical technician.
Risks and Complications
Common risks: Nausea, dizziness, drowsiness, headache. Rare risks: Respiratory depression, allergic reactions, confusion, hallucinations. Management: Close monitoring and, if necessary, administration of antidotes or supportive treatments.
Benefits
Expected benefits: Quick and effective pain relief, often within 15-20 minutes post-injection. How soon benefits are realized: Almost immediately for IV administration, within 15-30 minutes for intramuscular injections.
Recovery
Post-procedure care: Patients are generally advised to rest for a short period after the injection. Expected recovery time: No downtime required for recovery from the injection itself; however, the duration of pain relief varies and may require repeated doses. Restrictions and follow-up: Patients should follow up with their healthcare provider if pain persists or adverse effects occur.
Alternatives
Other treatment options: Oral pain medications, other opioid injections (e.g., morphine), non-opioid pain relievers, physical therapy. Pros and cons: Oral medications are less invasive but may take longer to work. Non-opioid alternatives may have fewer risks but might not provide sufficient pain relief.
Patient Experience
During the procedure: The patient might feel a brief sting at the injection site. After the procedure: Possible side effects include feeling drowsy or lightheaded. Pain relief typically begins shortly after the injection for IV administration and within 15-30 minutes for intramuscular. Pain management and comfort measures: Patients can discuss any discomfort or side effect concerns with their healthcare provider, who can offer measures such as hydration, rest, or additional medications to manage side effects.
J0595 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.